Gilead Sciences, Inc. (BVMF:GILD34)
331.32
-1.70 (-0.51%)
At close: Dec 4, 2025
15.77% (1Y)
| Market Cap | 806.12B |
| Revenue (ttm) | 155.02B |
| Net Income (ttm) | 43.22B |
| Shares Out | n/a |
| EPS (ttm) | 34.23 |
| PE Ratio | 18.65 |
| Forward PE | 14.72 |
| Dividend | 6.03 (1.81%) |
| Ex-Dividend Date | Sep 12, 2025 |
| Volume | 8 |
| Average Volume | 227 |
| Open | 331.32 |
| Previous Close | 333.02 |
| Day's Range | 331.32 - 331.32 |
| 52-Week Range | 273.00 - 347.34 |
| Beta | 0.33 |
| RSI | 53.63 |
| Earnings Date | Nov 6, 2025 |